Showing 1 - 12 results of 12 for search 'Philip O. Buck', query time: 0.03s
Refine Results
-
1
Time and cost of administering COVID-19 mRNA vaccines in the United States by Benjamin Yarnoff, Steven Bodhaine, Ed Cohen, Philip O. Buck
Published 2021-11-01
Article -
2
-
3
-
4
-
5
-
6
Early examination of real-world uptake and second-dose completion of recombinant zoster vaccine in the United States from October 2017 to September 2019 by Brandon J. Patterson, Chi-Chang Chen, Catherine B. McGuiness, Lisa I. Glasser, Kainan Sun, Philip O. Buck
Published 2021-08-01
Article -
7
The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program by Tinevimbo Shiri, Marc Evans, Carla A. Talarico, Angharad R. Morgan, Maaz Mussad, Philip O. Buck, Phil McEwan, William David Strain
Published 2022-01-01
Article -
8
Vaccinating Adolescents and Children Significantly Reduces COVID-19 Morbidity and Mortality across All Ages: A Population-Based Modeling Study Using the UK as an Example by Tinevimbo Shiri, Marc Evans, Carla A. Talarico, Angharad R. Morgan, Maaz Mussad, Philip O. Buck, Phil McEwan, William David Strain
Published 2021-10-01
Article -
9
Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live by Desmond Curran, Brandon J. Patterson, Desiree Van Oorschot, Philip O. Buck, Justin Carrico, Katherine A. Hicks, Bruce Lee, Barbara P. Yawn
Published 2019-04-01
Article -
10
A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development by Karen Fowler, Jacek Mucha, Monika Neumann, Witold Lewandowski, Magdalena Kaczanowska, Maciej Grys, Elvira Schmidt, Andrew Natenshon, Carla Talarico, Philip O. Buck, John Diaz-Decaro
Published 2022-09-01
Article -
11
New Vaccine Platforms—Novel Dimensions of Economic and Societal Value and Their Measurement by Philip O. Buck, Dumingu Aparna Gomes, Ekkehard Beck, Noam Kirson, Matthew Mattera, Stuart Carroll, Bernhard Ultsch, Kavisha Jayasundara, Mathieu Uhart, Louis P. Garrison, Jr.
Published 2024-02-01
Article -
12
Retrospective study of the use of an influenza disease two-tiered classification system to characterize clinical severity in US children by Amber Hsiao, Philip O. Buck, Arnold Yee, John Hansen, Edwin M. Lewis, Laurie L. Aukes, Emad Yanni, Rafik Bekkat-Berkani, Anne Schuind, Nicola P. Klein
Published 2020-08-01
Article